Clinical Trials on Metastatic Melanoma in United States
Total 6233 results
-
Mohammed M MilhemGenentech, Inc.TerminatedMelanoma | Metastatic Melanoma | BRAF-mutated Metastatic Melanoma | V600EBRAF-mutated Metastatic MelanomaUnited States
-
National Cancer Institute (NCI)National Institutes of Health Clinical Center (CC)TerminatedMetastatic Cancer | Metastatic MelanomaUnited States
-
National Cancer Institute (NCI)TerminatedMetastatic Uveal Melanoma | Metastatic Ocular MelanomaUnited States
-
MorphotekTerminatedMelanoma | Metastatic Melanoma | Advanced Melanoma | Malignant Metastatic MelanomaUnited States
-
University of Michigan Rogel Cancer CenterRecruitingMetastatic Melanoma | Liver Metastases | Melanoma, Mucosal | Melanoma, Ocular | Melanoma, CutaneousUnited States
-
Elizabeth DavisBristol-Myers SquibbTerminatedMetastatic Melanoma | Advanced Melanoma | Metastatic Melanoma Stratified by MHC-II ExpressionUnited States
-
Delcath Systems Inc.Active, not recruitingMetastatic Uveal Melanoma | Metastatic Ocular MelanomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingMelanoma | Metastatic Melanoma | Clinical Stage III Cutaneous Melanoma AJCC v8 | Recurrent Metastatic MelanomaUnited States
-
Dana-Farber Cancer InstitutePartner Therapeutics (PTx)WithdrawnMetastatic Melanoma | Unresectable Melanoma | Stage IV Melanoma | Stage III MelanomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteTurnstone Biologics, Corp.RecruitingMetastatic Melanoma | Conjunctival Melanoma | Ocular Melanoma | Unresectable Melanoma | Uveal Melanoma | Cutaneous Melanoma | Mucosal Melanoma | Iris Melanoma | Acral Melanoma | Non-Cutaneous MelanomaUnited States
-
Ohio State University Comprehensive Cancer CenterBristol-Myers SquibbUnknownLung Metastases | Liver Metastases | Recurrent Melanoma | Stage IV Melanoma | Tumors Metastatic to BrainUnited States
-
Craig L Slingluff, JrUniversity of VirginiaCompletedMelanoma | Metastatic Melanoma | Mucosal MelanomaUnited States
-
Ludwig Institute for Cancer ResearchUniversity of Chicago; University of Pittsburgh; Life Science PharmaceuticalsCompletedPhase II Study of KW2871 Combined With High Dose Interferon-α2b in Patients With Metastatic MelanomaMetastatic Melanoma | Cutaneous MelanomaUnited States
-
Dana-Farber Cancer InstituteAstraZenecaWithdrawnUveal Melanoma | Cutaneous Melanoma | Mucosal Melanoma | Recurrent Metastatic MelanomaUnited States
-
Lynn E. Spitler, MDGenentech, Inc.; Celgene CorporationCompletedMetastatic Malignant MelanomaUnited States
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific | Melanoma (Skin)United States
-
H. Lee Moffitt Cancer Center and Research InstituteActive, not recruitingLymphodepletion Plus Adoptive Cell Transfer With High Dose IL-2 in Patients With Metastatic MelanomaMetastatic MelanomaUnited States
-
National Cancer Institute (NCI)CompletedMetastatic MelanomaUnited States
-
University of LouisvilleJames Graham Brown Cancer CenterCompletedMetastatic MelanomaUnited States
-
University of LouisvilleJames Graham Brown Cancer CenterTerminatedMetastatic MelanomaUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers SquibbWithdrawn
-
University of Texas Southwestern Medical CenterWithdrawnMelanoma | Metastatic MelanomaUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompleted
-
University of Texas Southwestern Medical CenterNational Cancer Institute (NCI)Completed
-
Western Regional Medical CenterTerminated
-
NYU Langone HealthTerminatedMetastatic MelanomaUnited States
-
Gemin XTerminatedMetastatic MelanomaUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)Completed
-
National Cancer Institute (NCI)CompletedMetastatic MelanomaUnited States
-
Providence Health & ServicesPrometheus LaboratoriesActive, not recruitingMetastatic MelanomaUnited States
-
Masonic Cancer Center, University of MinnesotaCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteActive, not recruitingMetastatic MelanomaUnited States
-
F. Stephen Hodi, MDMedImmune LLCCompletedMetastatic MelanomaUnited States
-
Providence Health & ServicesProvidence Cancer Center, Earle A. Chiles Research Institute; Galectin Therapeutics...CompletedMetastatic MelanomaUnited States
-
Western Regional Medical CenterTerminated
-
University of Massachusetts, WorcesterCompleted
-
M.D. Anderson Cancer CenterAventis PharmaceuticalsCompleted
-
Molecular Insight Pharmaceuticals, Inc.TerminatedMetastatic MelanomaUnited States
-
M.D. Anderson Cancer CenterBristol-Myers SquibbCompleted
-
University of LouisvilleJames Graham Brown Cancer CenterActive, not recruitingMetastatic MelanomaUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedMetastatic MelanomaUnited States
-
Walter J. StorkusNational Cancer Institute (NCI)Completed
-
University of California, IrvineTerminatedMetastatic MelanomaUnited States
-
John P. FruehaufBayerCompletedMetastatic MelanomaUnited States
-
American Regent, Inc.Completed
-
Western Regional Medical CenterWithdrawnMetastatic MelanomaUnited States
-
John KirkwoodNational Cancer Institute (NCI); National Institutes of Health (NIH)Terminated
-
Beth Israel Deaconess Medical CenterGenzyme, a Sanofi CompanyCompletedMetastatic MelanomaUnited States
-
University of ChicagoCompletedMetastatic MelanomaUnited States
-
Providence Health & ServicesWithdrawn